HealthDay | New Drug Combo Might Help Older, Sicker Patients With Leukemia HealthDay The researchers, whose study was funded by the manufacturer of both obinutuzumab and rituximab, reported that the obinutuzumab-chlorambucil combination improved outcomes for the older CLL patients better than the other two treatment options. The most ... Anti-CD20 Antibody + Chemo Benefits CLL With Comorbidity |
